Alternatives to NRG Therapeutics
NRG Therapeutics is a Biotech tool: a biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to NRG Therapeutics
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
ANI Pharmaceuticals49BiotechBaudette, United States$670.5MDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
- Website
Ipsen33BiotechParis, FranceGlobal biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
- Website
Braeburn44BiotechPlymouth Meeting, United States$133.0MDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
- Website
Alto Neuroscience43BiotechLos Altos, United States$370.0MAlto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website Maasbiolabs37Biotech$1.0M
AI-powered platform accelerating biological research and drug discovery.
- Website
EyeGate Pharmaceuticals32BiotechWaltham, United States$45.5MClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
- Website
Tortugas Neuroscience51BiotechnologyFramingham, USA$164.0MAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
Orthogon Therapeutics49BiotechnologyCanton, USA$34.6MDeveloping first-in-class oral therapy for BK polyomavirus infections.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Lysoway Therapeutics48BiotechnologyCambridge, USA$45.0MDeveloping small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.
- Website
Draig Therapeutics48BiotechnologyNewton, United States$65.0MClinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
- Website
BenchSci64BiotechToronto, Canada$197.3MAI-powered platform for understanding disease biology and accelerating drug discovery.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
Showing the 20 closest matches. See the rest on the NRG Therapeutics profile.